Edwards Lifesciences Corp. | Mutual Funds
Mutual Funds that own Edwards Lifesciences Corp.
Vanguard Total Stock Market Index Fund
5,296,851
2.52%
21,646
0.1%
07/31/2018
Vanguard Mid Cap Index Fund
4,994,296
2.38%
25,129
0.7%
07/31/2018
Vanguard 500 Index Fund
3,816,324
1.82%
4,359
0.12%
07/31/2018
Government Pension Fund - Global (The)
3,103,337
1.48%
892,072
0.05%
12/31/2017
SPDR S&P 500 ETF
2,330,441
1.11%
26,908
0.12%
09/06/2018
Vanguard Institutional Index Fund
2,039,310
0.97%
2,383
0.12%
07/31/2018
Fidelity Contrafund
2,029,632
0.97%
77,162
0.22%
07/31/2018
Vanguard Growth Index Fund
1,484,308
0.71%
-4,488
0.25%
07/31/2018
Fidelity Spartan 500 Index Fund
1,404,040
0.67%
16,560
0.12%
07/31/2018
iShares Core S&P 500 ETF
1,403,967
0.67%
-3,250
0.12%
09/06/2018
| Address |
One Edwards Way
Irvine California 92614
United States
|
|
Employees
|
- |
| Website |
http://www.edwards.com |
| Updated |
07/08/2019 |
| Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. |
